PMGC Holdings Stock Rises As Subsidiary To Present At UCLA Symposium On Anti-Obesity Treatments

(RTTNews) - Shares of PMGC Holdings Inc. (ELAB) rose after the company said its subsidiary Northstrive Biosciences Inc. has been invited to present its lead muscle preservation asset EL-22 at the UCLA Obesity Symposium.

ELAB is currently trading at $2.8899, up $0.9099 or 45.9545%, on the Nasdaq.

The stock has experienced a notable increase in trading activity, with a volume of 74 million shares compared to its average volume of 1.3 million. The stock opened at $3.9801, after closing the previous day at $1.9800.

EL-22 is a novel myostatin asset aimed at preserving muscle while on weight loss treatments.